
### [MONDO:0016586](http://purl.obolibrary.org/obo/MONDO_0016586)
**Label:** systemic mastocytosis

**Subclasses:** [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0020333](http://purl.obolibrary.org/obo/MONDO_0020333) (aggressive systemic mastocytosis), [MONDO:0020334](http://purl.obolibrary.org/obo/MONDO_0020334) (mast cell leukemia), 

**Corr. equiv. classes:** [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:98850](http://www.orpha.net/ORDO/Orphanet_98850), [Orphanet:98851](http://www.orpha.net/ORDO/Orphanet_98851), 

**Class expressions from DL-Learner:**

- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 83.33%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 83.33%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 83.33%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 74.16%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 74.16%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 74.16%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 74.16%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 74.16%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and [HP:0100755](http://purl.obolibrary.org/obo/HP_0100755) (Abnormality of salivation) 66.67%
- [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%
- [HP:0004323](http://purl.obolibrary.org/obo/HP_0004323) (Abnormality of body weight) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%
- [HP:0002028](http://purl.obolibrary.org/obo/HP_0002028) (Chronic diarrhea) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%
- [HP:0001824](http://purl.obolibrary.org/obo/HP_0001824) (Weight loss) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%
- [HP:0000217](http://purl.obolibrary.org/obo/HP_0000217) (Xerostomia) and [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 66.67%


